Ifosfamide shortages affect 94% of centers, with notable constraints also reported for carboplatin, cisplatin, BCG, and ...

In "Inside the Be Well Trials: Design, Population, and Patient Selection," the panel walks through why the Be Well trials ...

In "Cross-Trial Vitiligo Data: What Payers Can and Can't Compare," the panel compares cross-trial data directly and discusses ...

This episode, "How Bepirovirsen Targets the Hepatitis B Viral Lifecycle," features the panel debating how much of this ...

Francesca Puggioni, MD, discusses real-world exacerbations, biomarker-driven access, and barriers to earlier biologic use in asthma and COPD. Panel discussions and abstract presentations at the ...

Economic modeling suggested meaningful savings via reduced disability costs and avoidance of inpatient admissions for compounded ophthalmic therapy, with projected annual patient savings of roughly ...

A higher weight-adjusted waist index (WWI) was independently linked to greater all-cause and CVD mortality in CKD, partly via ...

In "Counseling Vitiligo Patients on Time to Repigmentation," Dr. Desai and Dr. Lal discuss how to counsel patients through ...

AJMC: Your study found that emphysema affecting at least 20% of the lung on CT was consistently associated with differences ...

From a health system perspective, Martyn suggested that broader formulary access to finerenone makes sense as long as patient ...

CMS is withholding $9.8 billion in Texas Medicaid hospital funding tied to CHIRP, costing hospitals $27 million a day in a tax dispute.

Switching Medicare Advantage (MA) plans is increasingly common among MA enrollees, especially those dually eligible for ...